JPRN-UMIN000018942
Recruiting
未知
Establish a new algorithm for antiviral therapies based on HCV NS5A mutation status in patients with chronic hepatitis C infection. - New algorithm for antiviral therapies in patients with chronic hepatitis C.
agoya University0 sites230 target enrollmentJanuary 1, 2016
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- patients with chronic hepatitis C infection
- Sponsor
- agoya University
- Enrollment
- 230
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) liver failure 2\) liver chrosis for SMV group 3\) liver disease other than CHC 4\) HCC 5\) coinfection with HIV and/or HBV 6\) other than genotype 1b 7\) allegry for drugs i this study 8\) contraindication for drugs in this study 9\) pregnacy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Antiviral therapy with direct acting anti-virals in hepatitis C patients.Chronic hepatitis CJPRN-UMIN000016288Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine500
Completed
Not Applicable
Investigation of antiviral treatment for symptomatic congenital cytomegalovirus infectioCongenital cytomegalovirus infectionJPRN-UMIN000019464Department of Pediatrics, Nagoya University Graduate School of Medicine20
Not yet recruiting
Phase 3
Re-purposing of Anti HCV drugs for the treatment of COVID-19 diseasrHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/08/027345Pt B D Sharma post graduate institute of medical sciences
Unknown
Phase 4
The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia2019-nCoV Severe PneumoniaNCT04263402Tongji Hospital100
Unknown
Phase 4
A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia2019-nCoVNCT04254874Tongji Hospital100